CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells. Yuanjia Wen
Trends Immunol. 2025 Jan 30:S1471-4906(25)00001-8. doi: 10.1016/j.it.2025.01.001. Online ahead of print. ABSTRACT Tumor-infiltrating regulatory T (TI-Treg) cells constitute key components within the tumor microenvironment (TME) to suppress antitumor immunity and facilitate tumor progression. Although multiple therapies have been developed to eliminate TI-Treg cells, most of them exhibit only modest efficacy and harbor risks of inducing … Read more